A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)
Condition(s):Leptomeningeal Disease; Triple Negative Breast Cancer; HER2-positive Breast CancerLast Updated:March 12, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Leptomeningeal Disease; Triple Negative Breast Cancer; HER2-positive Breast CancerLast Updated:March 12, 2024Recruiting
Condition(s):Breast CancerLast Updated:April 13, 2017Unknown status
Condition(s):GlioblastomaLast Updated:January 11, 2024Completed
Condition(s):Dendritic Cells; Pancreatic NeoplasmsLast Updated:December 3, 2019Completed
Condition(s):Melanoma, Uveal MetastaticLast Updated:March 17, 2022Unknown status
Condition(s):Recurrent Ovarian CancerLast Updated:March 8, 2022Unknown status
Condition(s):Bladder CancerLast Updated:January 22, 2021Completed
Condition(s):GlioblastomaLast Updated:May 3, 2019Completed
Condition(s):Colorectal CancerLast Updated:July 12, 2017Unknown status
Condition(s):Breast Cancer; Triple Negative Breast CancerLast Updated:June 21, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.